(Q37965590)

26 August 2017

Apolipoprotein E mimetics and cholesterol-lowering properties (English)

1 reference

26 August 2017

Vinod K Mishra

5

1 reference

ORCID Public Data File 2021

author name string

Oleg F Sharifov

1

1 reference

26 August 2017

Gaurav Nayyar

2

1 reference

26 August 2017

David W Garber

3

1 reference

26 August 2017

Shaila P Handattu

4

1 reference

26 August 2017

Dennis Goldberg

6

1 reference

26 August 2017

G M Anantharamaiah

7

1 reference

26 August 2017

Himanshu Gupta

8

1 reference

26 August 2017

1 December 2011

1 reference

American journal of cardiovascular drugs

26 August 2017

1 reference

26 August 2017

11

1 reference

26 August 2017

6

1 reference

26 August 2017

371-381

1 reference

https://scigraph.springernature.com/pub.10.2165/11594190-000000000-00000

26 August 2017

0 references

cites work

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

HDL therapy for the acute treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E and atherosclerosis: insight from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E and atherosclerosis: beyond lipid effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: possible therapeutic target for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Expanding functions of lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E structure: insights into function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: far more than a lipid transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Putting cholesterol in its place: apoE and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E3- and nitric oxide-dependent modulation of endothelial cell inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

NMR structure and dynamics of a receptor-active apolipoprotein E peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Lipid-bound Structure of an Apolipoprotein E-derived Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Gene delivery to brain cells with apoprotein E derived peptide conjugated to polylysine (apoEdp-PLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

ApoE mimetic peptide decreases Abeta production in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E-derived peptides block alpha7 neuronal nicotinic acetylcholine receptors expressed in xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

A synthetic peptide of human apoprotein E with antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Dipalmitoylation of a cellular uptake-mediating apolipoprotein E-derived peptide as a promising modification for stable anchorage in liposomal drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Synthetic peptide analogs of apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Recent progress in understanding apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594190-000000000-00000

10.2165/11594190-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference